source
- Pfizer halts final Trillium study, redirects R&D funds to cancer and obesity programsPfizer announced it is ending the last clinical trial that originated from its 2021 purchase of Trillium Therapeutics. The company said the decision will free up cash that will be redirected to a…
- Madrigal secures fourth MASH partnership, snapping up Arrowhead drug passed over by J&JMadrigal Pharmaceuticals announced its latest collaboration, marking the fourth deal focused on metabolic dysfunction-associated steatohepatitis (MASH) within a ten‑month span. The agreement bring…